Cargando…

Management of severe ARDS due to SARS-CoV-2 pneumonia using low-flow extracorporeal CO(2) extraction

Detalles Bibliográficos
Autores principales:	Molina Lobo, Rosario, Lobo-Valbuena, Beatriz, Gordo, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522120/ https://www.ncbi.nlm.nih.gov/pubmed/34663415 http://dx.doi.org/10.1186/s13054-021-03777-1

Ejemplares similares

Assessment of pulmonary mechanics in mechanical ventilation
por: Gordo, Federico, et al.
Publicado: (2017)

Weekend effect: a great problem with a potential solution
por: Abella, Ana, et al.
Publicado: (2017)

Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications
por: Gordo, Federico, et al.
Publicado: (2022)

Update on the role of extracorporeal CO(2) removal as an adjunct to mechanical ventilation in ARDS
por: Morimont, Philippe, et al.
Publicado: (2015)

Low flow extracorporeal CO(2) removal in ARDS patients: a prospective short-term crossover pilot study
por: Peperstraete, Harlinde, et al.
Publicado: (2017)

Risk factors associated with the development of delirium in general ICU patients. A prospective observational study
por: Lobo-Valbuena, Beatriz, et al.
Publicado: (2021)

Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients
por: Redant, Sébastien, et al.
Publicado: (2020)

Defibrotide Therapy for SARS-CoV-2 ARDS
por: Frame, David, et al.
Publicado: (2022)

Validation of the P/FPE index in a cohort of patients with ARDS due to SARS-CoV-2
por: González-Castro, Alejandro, et al.
Publicado: (2023)

Use of Spironolactone in SARS-CoV-2 ARDS Patients
por: Dumanlı, Güleren Yartaş, et al.
Publicado: (2020)

Specific Treatment Exists for SARS-CoV-2 ARDS
por: Kanwar, Badar, et al.
Publicado: (2021)

(193) Coping with SARS-CoV-2-induced ARDS
por: Pancharovski, Tawnya, et al.
Publicado: (2022)

Functional independence, frailty and perceived quality of life in patients who developed delirium during ICU stay: a prospective cohort study
por: Lobo-Valbuena, Beatriz, et al.
Publicado: (2023)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
por: Mahida, Rahul Y, et al.
Publicado: (2020)

Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS
por: Mueller-Peltzer, Katharina, et al.
Publicado: (2020)

Endobronchial ultrasound is feasible and safe to diagnose pulmonary embolism in non-transportable SARS-CoV-2 ARDS patients requiring extracorporeal lung support
por: Decavele, Maxens, et al.
Publicado: (2020)

Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
por: Cure, Erkan, et al.
Publicado: (2020)

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS
por: Juanes-Velasco, Pablo, et al.
Publicado: (2022)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019)

High flow oxygen therapy in the treatment of SARS-CoV-2 pneumonia()
por: González-Castro, A., et al.
Publicado: (2022)

Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS
por: Schmidt, Matthieu, et al.
Publicado: (2018)

Extracorporeal membrane oxygenation for postpneumonectomy ARDS
por: Saueressig, Maurício Guidi, et al.
Publicado: (2014)

Extracorporeal membrane oxygenation in patients with SARS-CoV-2
por: dos Reis Filho, Valdir Assis, et al.
Publicado: (2020)

PULMONARY INFECTIONS IN PATIENTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR SARS-COV2-RELATED ARDS
por: HALANI, VARUN, et al.
Publicado: (2022)

Atypical pneumonia due to SARS-CoV-2: Clinical differentiation using the JRS pneumonia guidelines
por: Miyashita, Naoyuki
Publicado: (2022)

Impact of sweep gas flow on extracorporeal CO(2) removal (ECCO(2)R)
por: Strassmann, Stephan, et al.
Publicado: (2019)

Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2
por: Pagano, A., et al.
Publicado: (2020)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
por: McElvaney, Oisin F., et al.
Publicado: (2022)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

Indication of high-flow oxygen therapy in patients with SARS-CoV-2 pneumonia()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

High flow nasal cannula useful for severe SARSs-CoV-2 pneumonia
por: Ángel Mejía, V.E., et al.
Publicado: (2022)

High flow nasal cannula useful for severe SARSs-CoV-2 pneumonia
por: Ángel Mejía, V.E., et al.
Publicado: (2022)

Veno-venous extracorporeal membrane oxygenation in patients with SARS-CoV-2 pneumonia in Brazil: a case series
por: Brasil, Lucas Mendes Cunha de Resende, et al.
Publicado: (2023)

OUTCOMES OF EXTRACORPOREAL MEMBRANE OXYGENATION IN ARDS DUE TO COVID-19: COMPARISON OF THE FIRST AND THE SECOND WAVE
por: REDDY, ROHIT, et al.
Publicado: (2021)

Relative Low Flow Extra Corporeal Co(2)-Removal in Ards Patients: A Pilot Study
por: Peperstraete, H, et al.
Publicado: (2015)

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
por: Serrano Fernández, Leyre, et al.
Publicado: (2022)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
por: Antuña, Victoria Lobo, et al.
Publicado: (2023)

SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients
por: Buetti, Niccolò, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dp960ob031sp3uak7d38f7t7mp